Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care
Lucia Taramasso(Ospedale Policlinico San Martino), Matteo Bassetti(Ospedale Policlinico San Martino), Paolo Pelosi(Ospedale Policlinico San Martino), Laura Magnasco(Ospedale Policlinico San Martino), Silvia Dettori(Ospedale Policlinico San Martino), Chiara Dentone(Ospedale di Sanremo), Małgorzata Mikulska(Ospedale Policlinico San Martino), Raffaele D’Angelo(Ospedale Policlinico San Martino), Lorenzo Ball(Ospedale Policlinico San Martino), Daniele Roberto Giacobbe(Ospedale Policlinico San Martino), Antonio Vena(Ospedale Policlinico San Martino), Nicolò Patroniti(Ospedale Policlinico San Martino), Paolo Frisoni(Ospedale Policlinico San Martino), Chiara Robba(Ospedale Policlinico San Martino), Federica Portunato(Ospedale Policlinico San Martino), Federica Briano(University of Genoa), Maurizio Loconte(Ospedale Policlinico San Martino)
Cited by 11
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Mortality after surgery in Europe: a 7 day cohort study
|The Lancet|2012|1.4k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k